Literature DB >> 28913368

Erratum to "Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients".

Sang Jin Lee1,2, Won Park3, Sung Hwan Park4, Seung-Cheol Shim5, Han Joo Baek6, Dae-Hyun Yoo7, Hyun Ah Kim8, Soo Kon Lee9, Yun Jong Lee10, Young Eun Park11, Hoon-Suk Cha12, Jin Kyun Park1,2, Eun Young Lee1, Eun Bong Lee1, Yeong Wook Song1,2.   

Abstract

[This corrects the article DOI: 10.1155/2015/487230.].

Entities:  

Year:  2017        PMID： 28913368      PMCID： PMC5585674          DOI： 10.1155/2017/7869412

Source DB:  PubMed          Journal:  J Immunol Res        ISSN： 2314-7156            Impact factor:   4.818


In the article titled “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” [1], the name of the ninth author was given incorrectly as Yun Jong Leee. The author's name should have been written as Yun Jong Lee. The revised authors' list is shown above.
  1 in total

1.  Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.

Authors:  Sang Jin Lee; Won Park; Sung Hwan Park; Seung-Cheol Shim; Han Joo Baek; Dae-Hyun Yoo; Hyun Ah Kim; Soo Kon Lee; Yun Jong Leee; Young Eun Park; Hoon-Suk Cha; Jin Kyun Park; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  J Immunol Res       Date:  2015-04-02       Impact factor: 4.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.